Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1766767
PUBLISHER: GlobalData | PRODUCT CODE: 1766767
United States Hematological Disorders Market Outlook to 2033 - Hematology Tests and Hemostasis Tests
PUBLISHED:
PAGES: 52 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "United States Hematological Disorders Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Hematological Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Hematology Tests and Hemostasis Tests
The United States Hematological Disorders Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Hematological Disorders Market.
- Global corporate-level profiles of key companies operating within the United States Hematological Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Hematological Disorders is segmented as follows -
- Hematology Tests
- Hemostasis Tests
Reasons to Buy
The United States Hematological Disorders Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME25555CCDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Hematological Disorders Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Hematological Disorders Market, United States
- 3.1 Hematological Disorders Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Hematology Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Hemostasis Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.2 Hematological Disorders Market, United States, Volume (Units), 2018-2033
- 3.2.1 Hematology Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 Hemostasis Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.3 Hematological Disorders Market, United States, Average Price ($) , 2018-2033
- 3.4 Hematological Disorders Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Hematological Disorders Market
- 4.1 Abbott Laboratories
- 4.1.1 Company Overview
- 4.2 F. Hoffmann-La Roche Ltd
- 4.2.1 Company Overview
- 4.3 Sysmex Corp
- 4.3.1 Company Overview
- 4.4 Siemens AG
- 4.4.1 Company Overview
- 4.5 WerfenLife SA
- 4.5.1 Company Overview
- 4.6 Danaher Corp
- 4.6.1 Company Overview
- 4.7 Diagnostica Stago SAS
- 4.7.1 Company Overview
- 4.8 Quidel Corp
- 4.8.1 Company Overview
- 4.9 Thermo Fisher Scientific Inc
- 4.9.1 Company Overview
- 4.10 Siemens Healthineers AG
- 4.10.1 Company Overview
- 4.11 Horiba Ltd
- 4.11.1 Company Overview
- 4.12 EKF Diagnostics Holdings Plc
- 4.12.1 Company Overview
- 4.13 Bio-Rad Laboratories Inc
- 4.13.1 Company Overview
- 4.14 bioMerieux SA
- 4.14.1 Company Overview
5 Hematological Disorders Market Pipeline Products
6 Financial Deals Landscape
- 6.1 Equity Offerings
- 6.1.1 CurveBeam AI to Raise USD1.29 Million in Private Placement of Shares
- 6.1.2 CurveBeam AI (CurveBeamAI) Raises USD1.07 Million in Entitlement Rights Offering of Shares
- 6.2 Venture Financing
- 6.2.1 Mendaera Secures USD73 Million in Series B Funding
7 Recent Developments
- 7.1 Corporate Communications
- 7.1.1 Oct 16, 2024: PatientPoint CEO Sean Slovenski Shares Vision for Future of Health Care, Creates New Innovation Network Fueled by Partnerships and Appoints Chief Experience and Innovation Officer
- 7.1.2 Oct 02, 2024: Quanterix Adds Ivana Magovcevic-Liebisch to Board of Directors
- 7.1.3 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
- 7.1.4 Aug 19, 2024: Jeffrey Elliott Appointed to Quanterix's Board of Directors
- 7.2 Government and Public Interest
- 7.2.1 Jan 02, 2025: Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- 7.2.2 Aug 29, 2024: Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
- 7.2.3 Jun 17, 2024: Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
- 7.3 Other Significant Developments
- 7.3.1 Jan 13, 2025: Rigel Provides Business Update and 2025 Outlook
- 7.3.2 Jan 10, 2025: Quanterix To Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- And Tissue-Based Protein Biomarkers
- 7.4 Product News
- 7.4.1 Mar 18, 2025: Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting
- 7.4.2 Feb 04, 2025: Blood Test Eases Diagnosis of Invasive Mold Disease
- 7.4.3 Feb 03, 2025: At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors
- 7.4.4 Sep 17, 2024: The Results Of a Test Created In Barcelona For The Detection Of Multiple Cancers Are Presented at ESMO
8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
Product Code: GDME25555CCDB
List of Table
List of Tables
- Table 1: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 2: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 3: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 4: Hematological Disorders Market, United States, Volume (Units), 2018-2033
- Table 5: Hematology Tests Market, United States, Volume (Units), 2018-2033
- Table 6: Hemostasis Tests Market, United States, Volume (Units), 2018-2033
- Table 7: Hematological Disorders Market, United States, Average Price ($), 2018-2033
- Table 8: Hematological Disorders Market, United States, Company Share by Revenue ($m), 2024
- Table 9: Hematological Disorders Market Pipeline Products
- Table 10: CurveBeam AI to Raise USD1.29 Million in Private Placement of Shares
- Table 11: CurveBeam AI (CurveBeamAI) Raises USD1.07 Million in Entitlement Rights Offering of Shares
- Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figure
List of Figures
- Figure 1: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Hematological Disorders Market, United States, Volume (Units), 2018-2033
- Figure 5: Hematology Tests Market, United States, Volume (Units), 2018-2033
- Figure 6: Hemostasis Tests Market, United States, Volume (Units), 2018-2033
- Figure 7: Hematological Disorders Market, United States, Company Share (%), 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.